LATE-ONSET NEONATAL SEPSIS PREDICTIONS

A controller (150) includes a processor (152) that executes instructions to apply trained artificial intelligence to new measurements of vital signs of a neonatal patient and new laboratory results from laboratory tests of the neonatal patient, to changes between the new measurements of vital signs...

Full description

Saved in:
Bibliographic Details
Main Authors VIJ, SHRUTI GOPAL, TGAVALEKOS, KRISTEN, BOVERMAN, GREGORY
Format Patent
LanguageEnglish
Published 18.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A controller (150) includes a processor (152) that executes instructions to apply trained artificial intelligence to new measurements of vital signs of a neonatal patient and new laboratory results from laboratory tests of the neonatal patient, to changes between the new measurements of vital signs of the neonatal patient and previous measurements of vital signs of the neonatal patient, and to changes between the new laboratory results from laboratory tests of the neonatal patient and previous laboratory results from laboratory tests of the neonatal patient. The controller (150) is configured to compute, based on applying the trained artificial intelligence after retrieving the new measurements of vital signs of the neonatal patient and the new laboratory results from laboratory tests of the neonatal patient, a determination in advance indicating whether the neonatal patient will be diagnosable with late-onset neonatal sepsis.
Bibliography:Application Number: US202218289375